Anandamide levels in human female reproductive tissues: Solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry

Analytical Biochemistry

Volumn 400, Issue 2, 2010, Pages 155-162

  Marczylo, Timothy H ^a   Lam, Patricia M W ^a   Amoako, Akwasi A ^a   Konje, Justin C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Anandamide; Endocannabinoid; Solid phase extraction

Indexed keywords

HISTOLOGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEMBRANES; PHASE INTERFACES; PHASE SEPARATION; TISSUE;

ANANDAMIDE; ANANDAMIDE LEVELS; ENDOCANNABINOID; EXTRACTION EFFICIENCIES; ISOTOPE DILUTION METHODS; REPRODUCTIVE TISSUES; SOLID-PHASE EXTRACTION; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRIES;

EXTRACTION;

ANANDAMIDE;

ACCURACY; AMNION FLUID; ARTICLE; CESAREAN SECTION; CHEMICAL STRUCTURE; CHILDBIRTH; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FEMALE GENITAL SYSTEM; FETOPLACENTAL UNIT; FETUS MEMBRANE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ISOTOPE DILUTION ASSAY; MATERIALS HANDLING; MATERNAL BLOOD; PLACENTA; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TISSUE LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UMBILICAL ARTERY; UMBILICAL CORD BLOOD; UMBILICAL VEIN;

EID: 77950692392     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.12.025     Document Type: Article

References (36)

1. Conner C.S. Marijuana and alcohol use in pregnancy. Drug Intell. Clin. Pharm. 1984, 18:233-234.
2. Felder C.C., Glass M. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 1998, 38:179-200.
3. Hatch L.L., Bracken M.B. Effects of marijuana use in pregnancy on fetal growth. Am. J. Epidemiol. 1986, 124:986-993.
4. Zuckerman B., Frank D.A., Hingson R., Amaro H., Levenson S.M., Kayne H., Parker S., Vinci R., Aboagye K., Fried L.E., Cabral H., Timperi R., Bauchner H. Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. 1989, 320:762-768.
5. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
6. Mechoulam R., Ben-Shabat S., Hanuš L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Marg J., Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50:83-90.
7. 1 receptor. J. Pharmacol. Exp. Ther. 2002, 301:1020-1024.
8. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J. 2000, 351:817-824.
9. 1 receptor. Proc. Natl. Acad. Sci. USA 2001, 98:3662-3665.
10. Habayeb O.M.H., Taylor A.H., Evans M.D., Cooke M.S., Taylor D.J., Bell S.C., Konje J.C. Plasma levels of the endocannabinoid anandamide in women-A potential role in pregnancy maintenance and labor?. J. Clin. Endocrinol. Metab. 2004, 89:5482-5487.
11. Wang H., Dey S.K., Maccarrone M. Jekyll and Hyde: two faces of cannabinoid aboring in female fertility. Endocr. Rev. 2006, 27:427-448.
12. Taylor A.H., Ang C., Bell S.C., Konje J.C. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum. Reprod. Update 2007, 13:501-513.
13. Habayeb O.M.H., Taylor A.H., Finney M., Evans M.D., Konje J.C. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. J. Am. Med. Assoc. 2008, 299:1135-1136.
14. Schmid P.C., Paria B.C., Krebsbach R.J., Schmid H.H.O., Dey S.K. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. USA 1997, 94:4188-4192.
15. W Lam P.M., Marczylo T.H., El-Talatini M., Finney M., Nallendran V., Taylor A.H., Konje J.C. Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. Anal. Biochem. 2008, 380:195-201.
16. Maccarrone M., Bisogno T., Valensise H., Lazzarin N., Fezza F., Manna C., Di Marzo V., Finazzi-Agro A. Low fatty acid hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol. Hum. Reprod. 2002, 8:188-195.
17. Cella M., Leguizamón G.F., Sordelli M.S., Cervini M., Guadagnoli T., Ribeiro M.L., Franchi A.M., Farina M.G. Dual effects of anandamide on rat placenta nitric oxide synthesis. Placenta 2008, 29:699-707.
18. Park B., Gibbons H.M., Mitchell M.D., Glass M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003, 24:990-995.
19. Habayeb O.M.H., Taylor A.H., Bell S.C., Taylor D.J., Konje J.C. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 2008, 149:5052-5060.
20. T.H. Marczylo, J.C. Konje, Quantification of endocannabinoids in clinical samples: pitfalls and future directions, in: J.K. Lang (Ed.), Handbook on Mass Spectrometry: Instrumentation, Data and Analysis, and Applications, Nova Science, New York.
21. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer T.M., Maasson J.L., Schmid H.H.O. Occurrence and post-mortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 1995, 375:117-120.
22. Kempe K., Hsu F.F., Bohrer A., Turk J. Isotope dilution mass spectrometric measurements indicate that arachidonoylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J. Biol. Chem. 1996, 271:17287-17295.
23. Vogeser M., Hauer D., Azad S.C., Huber E., Storr M., Schelling G. Release of anandamide from blood cells. Clin. Chem. Lab. Med. 2006, 44:488-491.
24. Hardison S., Weintraub S.T., Giuffrida A. Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat. 2006, 81:106-112.
25. Marczylo T.H., Lam P.M.W., Nallendran V., Taylor A.H., Konje J.C. A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices. Anal. Biochem. 2009, 384:106-113.
26. Koga D., Santa T., Fukushima T., Homma H., Imai K. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues. J. Chromatogr. B 1997, 690:7-13.
27. Richardson D., Ortori C.A., Chapman V., Kendall D.A., Barrett D.A. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem. 2007, 360:216-226.
28. Williams J., Wood J., Pandarinathan L., Karanian D.A., Bahr B.A., Vouros P., Makriyannis A. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal. Chem. 2007, 79:5582-5593.
29. Kingsley P.J., Marnett L.J. Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry. Anal. Biochem. 2003, 314:8-15.
30. Acone G., Trabucco E., Colacurci N., Cobeliis L. Low type I cannabinoid receptor levels characterize placental villous in labouring delivery. Placenta 2009, 30:203-205.
31. Palkovits M., Harvey-White J., Liu J., Kovacs Z.S., Bobest M., Lovas G., Bago A.G., Kunos G. Regional distribution and effects of postmortem delay on endocannabinoid content of the human brain. Neuroscience 2008, 152:1032-1039.
32. Wang H., Xie H., Sun X., Kingsley P.J., Marnett L.J., Cravatt B.F., Dey S.K. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat. 2007, 83:62-74.
33. Schuel H., Burkman L.J., Lippes J., Crickard K., Forester E., Piomelli D., Giuffrida A. N-Acylethanolamines in human reproductive fluids. Chem. Phys. Lipids 2002, 121:211-227.
34. Balvers M.G.J., Verhoeckx K.C.M., Witkamp R.F. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2009, 877:1583-1590.
35. Thomas A., Hopfgartner G., Giroud C., Staub C. Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography. Rapid Commun. Mass Spectrom. 2009, 23:629-638.
36. Zoerner A.A., Gutzki F.M., Suchy M.T., Beckmann B., Engeli S., Jordan J., Tsikas D. Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma. J. Chromatogr. B 2009, 877:2909-2923.